Lice;nsing of DNA replication, cancer, pluripotency and differentiation: An interlinked world?

Seminars in Cell and Developmental Biology

Volumn 30, Issue , 2014, Pages 174-180

  Champeris Tsaniras, S ^a   Kanellakis, N ^a   Symeonidou, I E ^a   Nikolopoulou, P ^a   Lygerou, Z ^a   Taraviras, S ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cancer; Development; DNA replication; Licensing; Origin specification; Pluripotency

Indexed keywords

TRANSCRIPTION FACTOR;

CARCINOGENESIS; CELL DIFFERENTIATION; DEREGULATION; DNA REPLICATION; DNA REPLICATION ORIGIN; HUMAN; LICENSING; NEOPLASM; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; ANIMAL; CANCER STEM CELL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; PATHOLOGY; PHYSIOLOGY;

PHTHIRAPTERA;

ANIMALS; CELL DIFFERENTIATION; DNA REPLICATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; PLURIPOTENT STEM CELLS;

EID: 84901643165     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.03.013     Document Type: Review

References (136)

1. Blow J.J., Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 2005, 6:476-486.
2. Nishitani H., Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes Cells: Mol Cell Mech 2002, 7:523-534.
3. Nishitani H., Lygerou Z. DNA replication licensing. Front Biosci: J Virtual Library 2004, 9:2115-2132.
4. Symeonidou I.E., Taraviras S., Lygerou Z. Control over DNA replication in time and space. FEBS Lett 2012, 586:2803-2812.
5. McGarry T.J., Kirschner M.W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998, 93:1043-1053.
6. Flanagan J.F.P.C. A role for the yeast SWI/SNF complex in DNA replication. Nucleic Acids Res 1999, 27(May (9)):2022-2028.
7. Agherbi H., Gaussmann-Wenger A., Verthuy C., Chasson L., Serrano M., Djabali M. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS ONE 2009, 4:e5622.
8. De Stanchina E.G.D., Norio P., Giacca M., Peverali F.A., Riva S., Falaschi A., Biamonti G. Selection of homeotic proteins for binding to a human DNA replication origin. J Mol Biol 2000, 299(June (3)):667-680.
9. Comelli L.M.L., Arosio D., Riva S., Abdurashidova G., Beltram F., Falaschi A. The homeotic protein HOXC13 is a member of human DNA replication complexes. Cell Cycle 2009, 8(February (3)):454-459.
10. Marchetti L., Comelli L., D'Innocenzo B., Puzzi L., Luin S., Arosio D. Homeotic proteins participate in the function of human-DNA replication origins. Nucleic Acids Res 2010, 38:8105-8119.
11. DePamphilis M.L. Replication origins in metazoan chromosomes: fact or fiction. Bioessays 1999, 21:5-16.
12. MacAlpine D.M., Rodriguez H.K., Bell S.P. Coordination of replication and transcription along a Drosophila chromosome. Genes Dev 2004, 18:3094-3105.
13. Sequeira-Mendes J., Diaz-Uriarte R., Apedaile A., Huntley D., Brockdorff N., Gomez M. Transcription initiation activity sets replication origin efficiency in mammalian cells. PLoS Genet 2009, 5:e1000446.
14. Dellino G.I., Cittaro D., Piccioni R., Luzi L., Banfi S., Segalla S., et al. Genome-wide mapping of human DNA-replication origins: levels of transcription at ORC1 sites regulate origin selection and replication timing. Genome Res 2013, 23:1-11.
15. Cayrou C., Coulombe P., Vigneron A., Stanojcic S., Ganier O., Peiffer I., et al. Genome-scale analysis of metazoan replication origins reveals their organization in specific but flexible sites defined by conserved features. Genome Res 2011, 21:1438-1449.
16. MacAlpine D.M., Almouzni G. Chromatin and DNA replication. Cold Spring Harb Perspect Biol 2013, 5:a010207.
17. Dorn E.S., Cook J.G. Nucleosomes in the neighborhood: new roles for chromatin modifications in replication origin control. Epigenetics 2011, 6:552-559.
18. Cadoret J.C., Meisch F., Hassan-Zadeh V., Luyten I., Guillet C., Duret L., et al. Genome-wide studies highlight indirect links between human replication origins and gene regulation. Proc Natl Acad Sci U S A 2008, 105:15837-15842.
19. Unnikrishnan A., Gafken P.R., Tsukiyama T. Dynamic changes in histone acetylation regulate origins of DNA replication. Nat Struct Mol Biol 2010, 17:430-437.
20. Rizzardi L.F., Dorn E.S., Strahl B.D., Cook J.G. DNA replication origin function is promoted by H3K4 di-methylation in Saccharomyces cerevisiae. Genetics 2012, 192:371-384.
21. Fu H., Maunakea A.K., Martin M.M., Huang L., Zhang Y., Ryan M., et al. Methylation of histone H3 on lysine 79 associates with a group of replication origins and helps limit DNA replication once per cell cycle. PLoS Genet 2013, 9:e1003542.
22. Liu J., McConnell K., Dixon M., Calvi B.R. Analysis of model replication origins in Drosophila reveals new aspects of the chromatin landscape and its relationship to origin activity and the prereplicative complex. Mol Biol Cell 2012, 23:200-212.
23. Miotto B., Struhl K. HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by geminin. Mol Cell 2010, 37:57-66.
24. Wong P.G., Glozak M.A., Cao T.V., Vaziri C., Seto E., Alexandrow M. Chromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin. Cell Cycle 2010, 9:4351-4363.
25. Kuo A.J., Song J., Cheung P., Ishibe-Murakami S., Yamazoe S., Chen J.K., et al. The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome. Nature 2012, 484:115-119.
26. Chen X., Liu G., Leffak M. Activation of a human chromosomal replication origin by protein tethering. Nucleic Acids Res 2013, 41:6460-6474.
27. Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F., et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142:967-980.
28. Sideridou M., Zakopoulou R., Evangelou K., Liontos M., Kotsinas A., Rampakakis E., et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J Cell Biol 2011, 195:1123-1140.
29. Hayashida T., Oda M., Ohsawa K., Yamaguchi A., Hosozawa T., Locksley R.M., et al. Replication initiation from a novel origin identified in the Th2 cytokine cluster locus requires a distant conserved noncoding sequence. J Immunol 2006, 176:5446-5454.
30. Ghosh M., Liu G., Randall G., Bevington J., Leffak M. Transcription factor binding and induced transcription alter chromosomal c-myc replicator activity. Mol Cell Biol 2004, 24:10193-10207.
31. Gregoire D., Brodolin K., Mechali M. HoxB domain induction silences DNA replication origins in the locus and specifies a single origin at its boundary. EMBO Rep 2006, 7:812-816.
32. Kroll K.L., Salic A.N., Evans L.M., Kirschner M.W. Geminin: a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation. Development 1998, 125:3247-3258.
33. Spella M., Kyrousi C., Kritikou E., Stathopoulou A., Guillemot F., Kioussis D., et al. Geminin regulates cortical progenitor proliferation and differentiation. Stem Cells 2011, 29:1269-1282.
34. Karamitros D., Kotantaki P., Lygerou Z., Veiga-Fernandes H., Pachnis V., Kioussis D., et al. Differential geminin requirement for proliferation of thymocytes and mature T cells. J Immunol 2010, 184:2432-2441.
35. Karamitros D., Kotantaki P., Lygerou Z., Veiga-Fernandes H., Pachnis V., Kioussis D., et al. Life without geminin. Cell Cycle 2010, 9:3181-3185.
36. Luo L., Yang X., Takihara Y., Knoetgen H., Kessel M. The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature 2004, 427:749-753.
37. Del Bene F., Tessmar-Raible K., Wittbrodt J. Direct interaction of geminin and Six3 in eye development. Nature 2004, 427:745-749.
38. Seo S., Herr A., Lim J.W., Richardson G.A., Richardson H., Kroll K.L. Geminin regulates neuronal differentiation by antagonizing Brg1 activity. Genes Dev 2005, 19:1723-1734.
39. Seo S., Richardson G.A., Kroll K.L. The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD. Development 2005, 132:105-115.
40. Aigner S., Gage F.H. A small gem with great powers: geminin keeps neural progenitors thriving. Dev Cell 2005, 9:171-172.
41. Roukos V., Iliou M.S., Nishitani H., Gentzel M., Wilm M., Taraviras S., et al. Geminin cleavage during apoptosis by caspase-3 alters its binding ability to the SWI/SNF subunit Brahma. J Biol Chem 2007, 282:9346-9357.
42. Yang V.S., Carter S.A., Hyland S.J., Tachibana-Konwalski K., Laskey R.A., Gonzalez M.A. Geminin escapes degradation in G1 of mouse pluripotent cells and mediates the expression of Oct4, Sox2, and Nanog. Curr Biol 2011, 21:692-699.
43. Yellajoshyula D., Lim J.W., Thompson D.M., Witt J.S., Patterson E.S., Kroll K.L. Geminin regulates the transcriptional and epigenetic status of neuronal fate-promoting genes during mammalian neurogenesis. Mol Cell Biol 2012, 32:4549-4560.
44. Lim J.W., Hummert P., Mills J.C., Kroll K.L. Geminin cooperates with polycomb to restrain multi-lineage commitment in the early embryo. Development 2011, 138:33-44.
45. Yellajoshyula D., Patterson E.S., Elitt M.S., Kroll K.L. Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state. Proc Natl Acad Sci U S A 2011, 108:3294-3299.
46. Spella M., Britz O., Kotantaki P., Lygerou Z., Nishitani H., Ramsay R.G., et al. Licensing regulators geminin and Cdt1 identify progenitor cells of the mouse CNS in a specific phase of the cell cycle. Neuroscience 2007, 147:373-387.
47. Tikhmyanova N., Coleman T.R. Isoform switching of Cdc6 contributes to developmental cell cycle remodeling. Dev Biol 2003, 260:362-375.
48. Ryu S., Driever W. Minichromosome maintenance proteins as markers for proliferation zones during embryogenesis. Cell Cycle 2006, 5:1140-1142.
49. Ryu S., Holzschuh J., Erhardt S., Ettl A.K., Driever W. Depletion of minichromosome maintenance protein 5 in the zebrafish retina causes cell-cycle defect and apoptosis. Proc Natl Acad Sci U S A 2005, 102:18467-18472.
50. Pruitt S.C., Bailey K.J., Freeland A. Reduced Mcm2 expression results in severe stem/progenitor cell deficiency and cancer. Stem Cells 2007, 25:3121-3132.
51. Huang Z., Zang K., Reichardt L.F. The origin recognition core complex regulates dendrite and spine development in postmitotic neurons. J Cell Biol 2005, 170:527-535.
52. Cappuccio I., Colapicchioni C., Santangelo V., Sale P., Blandini F., Bonelli M., et al. The origin recognition complex subunit, ORC3, is developmentally regulated and supports the expression of biochemical markers of neuronal maturation in cultured cerebellar granule cells. Brain Res 2010, 1358:1-10.
53. Pinto S., Quintana D.G., Smith P., Mihalek R.M., Hou Z.H., Boynton S., et al. latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant. Neuron 1999, 23:45-54.
54. Bicknell L.S., Bongers E.M.H.F., Leitch A., Brown S., Schoots J., Harley M.E., et al. Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat Genet 2011, 43:356-359.
55. Bicknell L.S., Walker S., Klingseisen A., Stiff T., Leitch A., Kerzendorfer C., et al. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat Genet 2011, 43:350-355.
56. Klingseisen A., Jackson A.P. Mechanisms and pathways of growth failure in primordial dwarfism. Genes Dev 2011, 25:2011-2024.
57. Stiff T., Alagoz M., Alcantara D., Outwin E., Brunner H.G., Bongers E.M., et al. Deficiency in origin licensing proteins impairs cilia formation: implications for the aetiology of Meier-Gorlin syndrome. PLoS Genet 2013, 9:e1003360.
58. Hiratani I., Ryba T., Itoh M., Yokochi T., Schwaiger M., Chang C.W., et al. Global reorganization of replication domains during embryonic stem cell differentiation. PLoS Biol 2008, 6:e245.
59. Hiratani I., Ryba T., Itoh M., Rathjen J., Kulik M., Papp B., et al. Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis. Genome Res 2010, 20:155-169.
60. Ryba T., Hiratani I., Lu J., Itoh M., Kulik M., Zhang J., et al. Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. Genome Res 2010, 20:761-770.
61. Schultz S.S. DNA replication for pluripotent genes in human embryonic stem cells. Annual meeting of the Connecticut's stem cell research international symposium 2009.
62. Takebayashi S., Lei I., Ryba T., Sasaki T., Dileep V., Battaglia D., et al. Murine esBAF chromatin remodeling complex subunits BAF250a and Brg1 are necessary to maintain and reprogram pluripotency-specific replication timing of select replication domains. Epigenetics Chromatin 2013, 6:42.
63. Ho L.N., Jothi R., Ronan J.L., Cui K.R., Zhao K.J., Crabtree G.R. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A 2009, 106:5187-5191.
64. Foshay K.M., Looney T.J., Chari S., Mao F.F., Lee J.H., Zhang L., et al. Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol Cell 2012, 46:159-170.
65. Han D.W., Do J.T., Gentile L., Stehling M., Lee H.T., Scholer H.R. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 2008, 26:445-454.
66. Tsubouchi T., Soza-Ried J., Brown K., Piccolo F.M., Cantone I., Landeira D., et al. DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell 2013, 152:873-883.
67. Tabrizi G.A., Bose K., Reimann Y., Kessel M. Geminin is required for the maintenance of pluripotency. PLOS ONE 2013, 8:e73826.
68. Gonzalez M.A., Tachibana K.E., Adams D.J., van der Weyden L., Hemberger M., Coleman N., et al. Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development. Genes Dev 2006, 20:1880-1884.
69. Hara K., Nakayama K.I., Nakayama K. Geminin is essential for the development of preimplantation mouse embryos. Genes Cells 2006, 11:1281-1293.
70. Slawny N., O'Shea K.S. Geminin promotes an epithelial-to-mesenchymal transition in an embryonic stem cell model of gastrulation. Stem Cells Dev 2013, 22:1177-1189.
71. Campbell P.A., Perez-Iratxeta C., Andrade-Navarro M.A., Rudnicki M.A. Oct4 targets regulatory nodes to modulate stem cell function. PLoS ONE 2007, 2:e553.
72. Han J., Mistriotis P., Lei P., Wang D., Liu S., Andreadis S.T. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 2012, 30:2746-2759.
73. Gao Z., Cox J.L., Gilmore J.M., Ormsbee B.D., Mallanna S.K., Washburn M.P., et al. Determination of protein interactome of transcription factor Sox2 in embryonic stem cells engineered for inducible expression of four reprogramming factors. J Biol Chem 2012, 287:11384-11397.
74. Jaenisch R., Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008, 132:567-582.
75. Ray S., Pollard J.W. KLF15 negatively regulates estrogen-induced epithelial cell proliferation by inhibition of DNA replication licensing. Proc Natl Acad Sci U S A 2012, 109:E1334-E1343.
76. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008, 10:353-360.
77. Dominguez-Sola D., Ying C.Y., Grandori C., Ruggiero L., Chen B., Li M., et al. Non-transcriptional control of DNA replication by c-Myc. Nature 2007, 448:445-451.
78. Srinivasan S.V., Dominguez-Sola D., Wang L.C., Hyrien O., Gautier J. Cdc45 is a critical effector of Myc-dependent DNA replication stress. Cell Rep 2013, 3:1629-1639.
79. Dutta A. Chaotic license for genetic instability and cancer. Nat Genet 2007, 39:10-11.
80. Lau E., Tsuji T., Guo L., Lu S.H., Jiang W. The role of pre-replicative complex (pre-RC) components in oncogenesis. FASEB J: Off Publ Federation Am Soc Exp Biol 2007, 21:3786-3794.
81. Petropoulou C., Kotantaki P., Karamitros D., Taraviras S. Cdt1 and geminin in cancer: markers or triggers of malignant transformation?. Front Biosci 2008, 13:4485-4494.
82. Bravou V., Nishitani H., Song S.Y., Taraviras S., Varakis J. Expression of the licensing factors, Cdt1 and geminin, in human colon cancer. Int J Oncol 2005, 27:1511-1518.
83. Kim J., Feng H., Kipreos E.T. C. elegans CUL-4 prevents rereplication by promoting the nuclear export of CDC-6 via a CKI-1-dependent pathway. Curr Biol 2007, 17:966-972.
84. Liontos M., Koutsami M., Sideridou M., Evangelou K., Kletsas D., Levy B., et al. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res 2007, 67:10899-10909.
85. Vaziri C., Saxena S., Jeon Y., Lee C., Murata K., Machida Y., et al. A p53-dependent checkpoint pathway prevents rereplication. Mol Cell 2003, 11:997-1008.
86. Xouri G., Lygerou Z., Nishitani H., Pachnis V., Nurse P., Taraviras S. Cdt1 and geminin are down-regulated upon cell cycle exit and are over-expressed in cancer-derived cell lines. Eur J Biochem 2004, 271:3368-3378.
87. Karakaidos P., Taraviras S., Vassiliou L.V., Zacharatos P., Kastrinakis N.G., Kougiou D., et al. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas - synergistic effect with mutant p53 on tumor growth and chromosomal instability - evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol 2004, 165:1351-1365.
88. Seo J., Chung Y.S., Sharma G.G., Moon E., Burack W.R., Pandita T.K., et al. Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. Oncogene 2005, 24:8176-8186.
89. Gonzalez S., Klatt P., Delgado S., Conde E., Lopez-Rios F., Sanchez-Cespedes M., et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006, 440:702-706.
90. Murphy N., Ring M., Heffron C.C., King B., Killalea A.G., Hughes C., et al. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 2005, 58:525-534.
91. Going J.J., Keith W.N., Neilson L., Stoeber K., Stuart R.C., Williams G.H. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 2002, 50:373-377.
92. Honeycutt K.A., Chen Z., Koster M.I., Miers M., Nuchtern J., Hicks J., et al. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis. Oncogene 2006, 25:4027-4032.
93. Shetty A., Loddo M., Fanshawe T., Prevost A.T., Sainsbury R., Williams G.H., et al. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer 2005, 93:1295-1300.
94. Shima N., Alcaraz A., Liachko I., Buske T.R., Andrews C.A., Munroe R.J., et al. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet 2007, 39:93-98.
95. Shima N., Buske T.R., Schimenti J.C. Genetic screen for chromosome instability in mice - Mcm4 and breast cancer. Cell Cycle 2007, 6:1135-1140.
96. Chuang C.H., Wallace M.D., Abratte C., Southard T., Schimenti J.C. Incremental genetic perturbations to MCM2-7 expression and subcellular distribution reveal exquisite sensitivity of mice to DNA replication stress. PLoS Genet 2010, 6.
97. Quintana D.G., Thome K.C., Hou Z.H., Ligon A.H., Morton C.C., Dutta A. ORC5L: a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases. J Biol Chem 1998, 273:27137-27145.
98. Gurevich R.M., Aplan P.D., Humphries R.K. NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood 2004, 104:1127-1136.
99. Nebral K., Schmidt H.H., Haas O.A., Strehl S. NUP98 is fused to topoisomerase (DNA) IIbeta 180kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15). Clin Cancer Res: Off J Am Assoc Cancer Res 2005, 11:6489-6494.
100. Panagopoulos I., Isaksson M., Billstrom R., Strombeck B., Mitelman F., Johansson B. Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer 2003, 36:107-112.
101. Gough S.M., Slape C.I., Aplan P.D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011, 118:6247-6257.
102. Melixetian M., Ballabeni A., Masiero L., Gasparini P., Zamponi R., Bartek J., et al. Loss of geminin induces rereplication in the presence of functional p53. J Cell Biol 2004, 165:473-482.
103. Mihaylov I.S., Kondo T., Jones L., Ryzhikov S., Tanaka J., Zheng J.Y., et al. Control of DNA replication and chromosome ploidy by geminin and cyclin A. Mol Cell Biol 2002, 22:1868-1880.
104. Zhu W.G., Chen Y.F., Dutta A. Rereplication by depletion of geminin is seen regardless of p53 status and activates a G(2)/M checkpoint. Mol Cell Biol 2004, 24:7140-7150.
105. Tachibana K.E.K., Gonzalez M.A., Guarguaglini G., Nigg E.A., Laskey R.A. Depletion of licensing inhibitor geminin causes centrosome overduplication and mitotic defects. EMBO Rep 2005, 6:1052-1057.
106. Di Bonito M., Cantile M., Collina F., Scognamiglio G., Cerrone M., La Mantia E., et al. Overexpression of cell cycle progression inhibitor geminin is associated with tumor stem-like phenotype of triple-negative breast cancer. J Breast Cancer 2012, 15:162-171.
107. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 2008, 3:e2637.
108. Kumar S.M., Liu S., Lu H., Zhang H., Zhang P.J., Gimotty P.A., et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 2012, 31:4898-4911.
109. Wang Y.D., Cai N., Wu X.L., Cao H.Z., Xie L.L., Zheng P.S. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis 2013, 4:e760.
110. Herreros-Villanueva M., Zhang J.S., Koenig A., Abel E.V., Smyrk T.C., Bamlet W.R., et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2013, 2:e61.
111. Chen S., Xu Y., Chen Y., Li X., Mou W., Wang L., et al. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS ONE 2012, 7:e36326.
112. Ibrahim E.E., Babaei-Jadidi R., Saadeddin A., Spencer-Dene B., Hossaini S., Abuzinadah M., et al. Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms. Stem Cells 2012, 30:2076-2087.
113. Noh K.H., Kim B.W., Song K.H., Cho H., Lee Y.H., Kim J.H., et al. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest 2012, 122:4077-4093.
114. Lu X., Mazur S.J., Lin T., Appella E., Xu Y. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 2013.
115. Prochownik E.V. c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther 2004, 4:289-302.
116. Leng Z., Tao K., Xia Q., Tan J., Yue Z., Chen J., et al. Kruppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLOS ONE 2013, 8:e56082.
117. Yu F., Li J., Chen H., Fu J., Ray S., Huang S., et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.
118. Bruggeman S.W., Hulsman D., Tanger E., Buckle T., Blom M., Zevenhoven J., et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007, 12:328-341.
119. Viswanathan S.R., Powers J.T., Einhorn W., Hoshida Y., Ng T.L., Toffanin S., et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009, 41:843-848.
120. Bracken A.P., Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009, 9:773-784.
121. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011, 71:6320-6326.
122. Wilson B.G., Roberts C.W. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011, 11:481-492.
123. Wong A.K., Shanahan F., Chen Y., Lian L., Ha P., Hendricks K., et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000, 60:6171-6177.
124. Glaros S., Cirrincione G.M., Palanca A., Metzger D., Reisman D. Targeted knockout of BRG1 potentiates lung cancer development. Cancer Res 2008, 68:3689-3696.
125. Becker T.M., Haferkamp S., Dijkstra M.K., Scurr L.L., Frausto M., Diefenbach E., et al. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Mol Cancer 2009, 8:4.
126. Guo W.J., Datta S., Band V., Dimri G.P. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 2007, 18:536-546.
127. Ray M.K., Wang Y., Borowsky M., Sadreyev R., Kingston R.E. Identifying candidate ncRNAs that direct changes in chromatin structure. Epigenetics Chromatin 2013, 6:69.
128. Glaser K.B., Staver M.J., Waring J.F., Stender J., Ulrich R.G., Davidsen S.K. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther 2003, 2:151-163.
129. Williams J.C., Kizaki H., Weber G., Morris H.P. Increased CTP synthetase activity in cancer cells. Nature 1978, 271:71-73.
130. Ellims P.H., Gan T.E., Medley G. Cytidine triphosphate synthetase activity in lymphoproliferative disorders. Cancer Res 1983, 43:1432-1435.
131. Whelan J., Smith T., Phear G., Rohatiner A., Lister A., Meuth M. Resistance to cytosine arabinoside in acute leukemia: the significance of mutations in CTP synthetase. Leukemia 1994, 8:264-265.
132. Weber G., Lui M.S., Takeda E., Denton J.E. Enzymology of human colon tumors. Life Sci 1980, 27:793-799.
133. Kizaki H., Williams J.C., Morris H.P., Weber G. Increased cytidine 5'-triphosphate synthetase activity in rat and human tumors. Cancer Res 1980, 40:3921-3927.
134. Piergentili R. How complex an intron may be? The example of the first intron of the CTP synthase gene of Drosophila melanogaster. J Mol Biochem 2013, 2:27-39.
135. Valenzuela M.S., Hu L., Lueders J., Walker R., Meltzer P.S. Broader utilization of origins of DNA replication in cancer cell lines along a 78kb region of human chromosome 2q34. J Cell Biochem 2012, 113:132-140.
136. Di Paola D., Price G.B., Zannis-Hadjopoulos M. Differentially active origins of DNA replication in tumor versus normal cells. Cancer Res 2006, 66:5094-5103.